175 related articles for article (PubMed ID: 8450517)
1. Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension.
Landmark K; Thaulow E; Hysing J; Mundal HH; Eritsland J; Hjermann I
J Hum Hypertens; 1993 Feb; 7(1):25-32. PubMed ID: 8450517
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
[TBL] [Abstract][Full Text] [Related]
3. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
4. Effect of fish oil on blood pressure and serum lipids in hypertension and hyperlipidaemia.
Steiner A; Oertel R; Bättig B; Pletscher W; Weiss B; Greminger P; Vetter W
J Hypertens Suppl; 1989 May; 7(3):S73-6. PubMed ID: 2547916
[TBL] [Abstract][Full Text] [Related]
5. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
Bairati I; Roy L; Meyer F
Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
[TBL] [Abstract][Full Text] [Related]
6. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia.
Bunea R; El Farrah K; Deutsch L
Altern Med Rev; 2004 Dec; 9(4):420-8. PubMed ID: 15656713
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
[TBL] [Abstract][Full Text] [Related]
9. Fish oil as an adjuvant in the treatment of hypertension.
Gray DR; Gozzip CG; Eastham JH; Kashyap ML
Pharmacotherapy; 1996; 16(2):295-300. PubMed ID: 8820475
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
11. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
[TBL] [Abstract][Full Text] [Related]
12. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.
Yosefy C; Viskoper JR; Varon D; Ilan Z; Pilpel D; Lugassy G; Schneider R; Savyon N; Adan Y; Raz A
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S135-9. PubMed ID: 8872845
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
14. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.
Bowden RG; Wilson RL; Deike E; Gentile M
Nutr Clin Pract; 2009; 24(4):508-12. PubMed ID: 19461006
[TBL] [Abstract][Full Text] [Related]
15. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
Agren JJ; Hänninen O; Julkunen A; Fogelholm L; Vidgren H; Schwab U; Pynnönen O; Uusitupa M
Eur J Clin Nutr; 1996 Nov; 50(11):765-71. PubMed ID: 8933125
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
[TBL] [Abstract][Full Text] [Related]
17. [Effect on the lipid profile of diet supplemented with fish oil concentrate].
Bøhn KA; Friisk CF; Bøe OW; Hysing J
Tidsskr Nor Laegeforen; 1990 May; 110(13):1693-6. PubMed ID: 2195704
[TBL] [Abstract][Full Text] [Related]
18. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
Castro IA; Monteiro VC; Barroso LP; Bertolami MC
Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
20. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.
Radack K; Deck C; Huster G
Arch Intern Med; 1991 Jun; 151(6):1173-80. PubMed ID: 1828336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
